{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:22:19Z","timestamp":1761128539199},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.vaccine.2006.11.012","type":"journal-article","created":{"date-parts":[[2006,11,21]],"date-time":"2006-11-21T19:53:40Z","timestamp":1164138820000},"page":"1581-1592","source":"Crossref","is-referenced-by-count":22,"title":["Vaccine potential for inactivated shigellae"],"prefix":"10.1016","volume":"25","author":[{"given":"Manuel","family":"Osorio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mechelle D.","family":"Bray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard I.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2006.11.012_bib1","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Org"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.012_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/oxfordjournals.aje.a112277","article-title":"Shigellosis in custodial institutions. V. Effect of intervention with streptomycin-dependent Shigella sonnei vaccine in an institution with endemic disease","volume":"104","author":"Levine","year":"1976","journal-title":"Am J Epidemiol"},{"issue":"8932","key":"10.1016\/j.vaccine.2006.11.012_bib3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(94)90755-2","article-title":"Protective efficacy of oral whole-cell\/recombinant-B-subunit cholera vaccine in Peruvian military recruits","volume":"344","author":"Sanchez","year":"1994","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.012_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.femsre.2003.07.002","article-title":"Shigella flexneri infection: pathogenesis and vaccine development","volume":"28","author":"Jennison","year":"2004","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.012_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/JB.92.1.17-22.1966","article-title":"Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine","volume":"92","author":"Formal","year":"1966","journal-title":"J Bacteriol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.012_bib6","first-page":"457","article-title":"Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains","volume":"45","author":"Mel","year":"1971","journal-title":"Bull World Health Org"},{"issue":"7","key":"10.1016\/j.vaccine.2006.11.012_bib7","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"Coster","year":"1999","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.012_bib8","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/IAI.70.4.2016-2021.2002","article-title":"Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults","volume":"70","author":"Kotloff","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.012_bib9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/IAI.72.2.923-930.2004","article-title":"Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers","volume":"72","author":"Katz","year":"2004","journal-title":"Infect Immun"},{"issue":"9046","key":"10.1016\/j.vaccine.2006.11.012_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","article-title":"Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"issue":"9047","key":"10.1016\/j.vaccine.2006.11.012_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","article-title":"Field trial of a locally produced, killed, oral cholera vaccine in Vietnam","volume":"349","author":"Trach","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.012_bib12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.012_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/IAI.64.1.23-27.1996","article-title":"Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli","volume":"64","author":"Noriega","year":"1996","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2006.11.012_bib14","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1128\/IAI.64.11.4542-4548.1996","article-title":"Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG","volume":"64","author":"Kotloff","year":"1996","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2006.11.012_bib15","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/IAI.70.6.2950-2958.2002","article-title":"Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine","volume":"70","author":"Venkatesan","year":"2002","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.11.012_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-1759(00)00171-X","article-title":"Measurement of specific IgA in faecal extracts and intestinal lavage fluid for monitoring of mucosal immune responses","volume":"239","author":"Grewal","year":"2000","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.012_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1651-2227.1999.tb01075.x","article-title":"Killed oral Shigella vaccine made from Shigella flexneri 2a protects against challenge in the rabbit model of shigellosis","volume":"88","author":"Chakrabarti","year":"1999","journal-title":"Acta Paediatr"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2006.11.012_bib18","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/S0264-410X(03)00111-7","article-title":"Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition","volume":"21","author":"Mukhopadhaya","year":"2003","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2006.11.012_bib19","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1128\/IAI.67.11.5841-5847.1999","article-title":"Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines","volume":"67","author":"Hartman","year":"1999","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.012_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00006454-200204000-00012","article-title":"Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants","volume":"21","author":"Savarino","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2006.11.012_bib21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.012_bib22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0952-7915(99)80066-1","article-title":"The role of dendritic cells in the induction and regulation of immunity to microbial infection","volume":"11","author":"Reis e Sousa","year":"1999","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.012_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/86373","article-title":"Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria","volume":"2","author":"Rescigno","year":"2001","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.012_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0952-7915(02)00365-5","article-title":"How dendritic cells and microbes interact to elicit or subvert protective immune responses","volume":"14","author":"Palucka","year":"2002","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.11.012_bib25","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/1521-4141(200205)32:5<1464::AID-IMMU1464>3.0.CO;2-G","article-title":"Cytotoxicity and interleukin-1beta processing following Shigella flexneri infection of human monocyte-derived dendritic cells","volume":"32","author":"Edgeworth","year":"2002","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.11.012_bib26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1074-7613(00)80209-5","article-title":"Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation","volume":"12","author":"Sansonetti","year":"2000","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.vaccine.2006.11.012_bib27","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.4049\/jimmunol.167.9.5067","article-title":"Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo","volume":"167","author":"Pulendran","year":"2001","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.11.012_bib28","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1128\/IAI.72.12.7045-7054.2004","article-title":"Yersinia enterocolitica induces apoptosis and inhibits surface molecule expression and cytokine production in murine dendritic cells","volume":"72","author":"Erfurth","year":"2004","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2006.11.012_bib29","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1128\/IAI.71.7.4163-4166.2003","article-title":"Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells","volume":"71","author":"Guiney","year":"2003","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2006.11.012_bib30","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1128\/IAI.72.8.4416-4423.2004","article-title":"Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori","volume":"72","author":"Kranzer","year":"2004","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.012_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1189\/jlb.69.4.583","article-title":"Genetic background of attenuated Salmonella typhimurium has profound influence on infection and cytokine patterns in human dendritic cells","volume":"69","author":"Dreher","year":"2001","journal-title":"J Leukoc Biol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.11.012_bib32","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1128\/IAI.72.10.5535-5547.2004","article-title":"Enteric pathogens as vaccine vectors for foreign antigen delivery","volume":"72","author":"Kotton","year":"2004","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2006.11.012_bib33","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0264-410X(94)90293-3","article-title":"Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers","volume":"12","author":"Cardenas","year":"1994","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2006.11.012_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.copbio.2004.10.004","article-title":"Bacterial ghosts-biological particles as delivery systems for antigens, nucleic acids and drugs","volume":"15","author":"Tabrizi","year":"2004","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.012_bib35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/IAI.73.1.258-267.2005","article-title":"Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608(pCFAI) and SC608(pCFAI\/LTB) that express antigens from enterotoxigenic Escherichia coli","volume":"73","author":"Ranallo","year":"2005","journal-title":"Infect Immun"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2006.11.012_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0264-410X(02)00611-4","article-title":"Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains","volume":"21","author":"Barry","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.012_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0264-410X(03)00558-9","article-title":"Bordetella pertussis can act as adjuvant as well as inhibitor of immune responses to non-replicating nasal vaccines","volume":"22","author":"Haugan","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2006.11.012_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1574-6968.1988.tb02363.x","volume":"1","author":"Evans","year":"1988","journal-title":"FEMS Microbiol Immunol"},{"issue":"9380","key":"10.1016\/j.vaccine.2006.11.012_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0140-6736(03)13971-2","article-title":"Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study","volume":"362","author":"Steinsland","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.012_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/IAI.71.1.13-21.2003","article-title":"Pathogenicity and immune response measured in mice following intranasal challenge with enterotoxigenic Escherichia coli strains H10407 and B7A","volume":"71","author":"Byrd","year":"2003","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.11.012_bib41","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/IAI.67.2.782-788.1999","article-title":"Strategy for cross-protection among Shigella flexneri serotypes","volume":"67","author":"Noriega","year":"1999","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06012102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06012102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T19:33:50Z","timestamp":1683660830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06012102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0264410X06012102"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.11.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}